(MedPage Today) — The European Medicines Agency has called for stronger safety warnings for the multiple sclerosis drug fingolimod (Gilenya), and drugmaker Novartis said the FDA has agreed to similar label updates.
No Comments »
Filed under: General Health News
Two new studies analyzing treatment decisions in late-stage amyotrophic lateral sclerosis (ALS) patients shed light onto treatments aimed to extend the duration and quality of life in this progressively debilitating neuromuscular disorder.
No Comments »
Filed under: Pharmacy News
People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as [...]
No Comments »
Filed under: Pharmacy News
Doctors at several centers across the U.S. are recruiting people who have multiple sclerosis (MS) to determine the effectiveness of high-dose vitamin D supplements for reducing MS disease activity.
No Comments »
Filed under: Pharmacy News
An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science at the American Academy of Neurology’s 64th Annual Meeting in New Orleans April 21 to April 28, 2012.
No Comments »
Filed under: Pharmacy News
Neuralstem, Inc. announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cells, on March 13th.
No Comments »
Filed under: Pharmacy News
A genetic pathway previously known for its role in embryonic development and cancer has been identified as a target for systemic sclerosis, or scleroderma, therapy…
No Comments »
Filed under: Women's Health
The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is characterized by periods when symptoms [...]
No Comments »
Filed under: Pharmacy News
A new study suggests that administering FTY720, an oral drug that has shown promise in trials for human multiple sclerosis, significantly improves locomotor recovery in mice with spinal cord injury.
No Comments »
Filed under: Pharmacy News
A new class of drugs completing clinical trials soon for rheumatoid arthritis should be examined as a treatment for multiple sclerosis, according to the authors of a University of Alabama at Birmingham study published today in the Proceedings of the National Academy of Sciences.
No Comments »
Filed under: Pharmacy News
